Autoimmune polyendocrine syndrome history and symptoms: Difference between revisions
Jump to navigation
Jump to search
Iqra Qamar (talk | contribs) |
No edit summary |
||
| (3 intermediate revisions by one other user not shown) | |||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
A detailed [[History & Symptoms|history]] may be helpful in the early [[diagnosis]] of the autoimmune polyendocrine syndrome (APS). Autoimmune polyendocrine syndrome [[patients]] generally have an early onset. In such cases, history from the caregivers may be obtained. An important aspect involves obtaining [[family history]] about the presence of APS in family members since APS can be transmitted in [[genetic]] mode. [[Patients]] with the autoimmune polyendocrine syndrome (APS) have varied [[symptoms]] depending on the subtype. The most common presentation of APS-1 include mucocutaneous [[candidiasis]], [[hypoparathyroidism]] and [[Addison's disease]]. The most common presentation of APS-2 include [[Addison's disease]] with [[autoimmune thyroiditis]] or [[diabetes mellitus type 1]]. The most common presentation of APS 3 include [[autoimmune thyroiditis]], [[diabetes mellitus type 1]], [[pernicious anemia]] and/or with involvement of a | A detailed [[History & Symptoms|history]] may be helpful in the early [[diagnosis]] of the autoimmune polyendocrine syndrome (APS). Autoimmune polyendocrine syndrome [[patients]] generally have an early onset. In such cases, history from the caregivers may be obtained. An important aspect involves obtaining [[family history]] about the presence of APS in family members since APS can be transmitted in [[genetic]] mode. [[Patients]] with the autoimmune polyendocrine syndrome (APS) have varied [[symptoms]] depending on the subtype. The most common presentation of APS-1 include mucocutaneous [[candidiasis]], [[hypoparathyroidism]] and [[Addison's disease]]. The most common presentation of APS-2 include [[Addison's disease]] with [[autoimmune thyroiditis]] or [[diabetes mellitus type 1]]. The most common presentation of APS 3 include [[autoimmune thyroiditis]], [[diabetes mellitus type 1]], [[pernicious anemia]] and/or with involvement of a non-[[endocrine]] [[Organ (anatomy)|organ]]. | ||
==History== | ==History== | ||
Obtaining | Obtaining a detailed history is an important aspect in making a [[diagnosis]] of autoimmune polyendocrine syndrome (APS). It provides insight into the [[Causality|cause]], precipitating factors and associated [[comorbid]] conditions. It also helps in determining the correct [[therapy]] and the [[prognosis]]. Autoimmune polyendocrine syndrome [[patients]] generally have an early onset. In such cases [[History & Symptoms|history]] from the care givers or the family members may need to be obtained. Specific areas of focus while obtaining history, are outlined below:<ref name="pmid25905309">{{cite journal |vauthors=De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, Nicolaides NC, Chrousos, Charmandari E |journal= |volume= |issue= |pages= |year= |pmid=25905309 |doi= |url=}}</ref><ref name="pmid12050215">{{cite journal |vauthors=Halonen M, Eskelin P, Myhre AG, Perheentupa J, Husebye ES, Kämpe O, Rorsman F, Peltonen L, Ulmanen I, Partanen J |title=AIRE mutations and human leukocyte antigen genotypes as determinants of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy phenotype |journal=J. Clin. Endocrinol. Metab. |volume=87 |issue=6 |pages=2568–74 |year=2002 |pmid=12050215 |doi=10.1210/jcem.87.6.8564 |url=}}</ref><ref name="pmid10633830">{{cite journal |vauthors=Borgaonkar MR, Morgan DG |title=Primary biliary cirrhosis and type II autoimmune polyglandular syndrome |journal=Can. J. Gastroenterol. |volume=13 |issue=9 |pages=767–70 |year=1999 |pmid=10633830 |doi= |url=}}</ref> | ||
* Onset, duration and progression of [[symptoms]] (mucocutaneous [[candidiasis]], [[hypoparathyroidism]] and [[adrenal failure]]) | * Onset, duration and progression of [[symptoms]] (mucocutaneous [[candidiasis]], [[hypoparathyroidism]] and [[adrenal failure]]) | ||
| Line 14: | Line 14: | ||
* Associated [[symptoms]] ([[lethargy]], [[fever]], [[confusion]]) | * Associated [[symptoms]] ([[lethargy]], [[fever]], [[confusion]]) | ||
* [[Medications]] | * [[Medications]] | ||
* Symptoms of other [[organ failure]] ([[renal failure]], [[liver failure]], [[adrenal failure]]) | * [[Symptoms]] of other [[organ failure]] ([[renal failure]], [[liver failure]], [[adrenal failure]]) | ||
* [[Comorbid]] conditions like [[diabetes]], [[immunodeficiency]] | * [[Comorbid]] conditions like [[diabetes]], [[immunodeficiency]] | ||
* [[Sepsis|Severe infections]] | * [[Sepsis|Severe infections]] | ||
| Line 24: | Line 24: | ||
APS type 1 commonly presents in infancy. The symptoms include:<ref name="pmid22460196">{{cite journal |vauthors=Weiler FG, Dias-da-Silva MR, Lazaretti-Castro M |title=Autoimmune polyendocrine syndrome type 1: case report and review of literature |journal=Arq Bras Endocrinol Metabol |volume=56 |issue=1 |pages=54–66 |year=2012 |pmid=22460196 |doi= |url=}}</ref><ref name="pmid17202607">{{cite journal |vauthors=Joshi RR, Rao S, Prabhu SS |title=Polyglandular autoimmune syndrome-type I |journal=Indian Pediatr |volume=43 |issue=12 |pages=1085–7 |year=2006 |pmid=17202607 |doi= |url=}}</ref><ref name="pmid19411300">{{cite journal |vauthors=Kahaly GJ |title=Polyglandular autoimmune syndromes |journal=Eur. J. Endocrinol. |volume=161 |issue=1 |pages=11–20 |year=2009 |pmid=19411300 |doi=10.1530/EJE-09-0044 |url=}}</ref><ref name="pmid24503135">{{cite journal |vauthors=Charmandari E, Nicolaides NC, Chrousos GP |title=Adrenal insufficiency |journal=Lancet |volume=383 |issue=9935 |pages=2152–67 |year=2014 |pmid=24503135 |doi=10.1016/S0140-6736(13)61684-0 |url=}}</ref><ref name="pmid2348835">{{cite journal |vauthors=Ahonen P, Myllärniemi S, Sipilä I, Perheentupa J |title=Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients |journal=N. Engl. J. Med. |volume=322 |issue=26 |pages=1829–36 |year=1990 |pmid=2348835 |doi=10.1056/NEJM199006283222601 |url=}}</ref><ref name="pmid9543115">{{cite journal |vauthors=Betterle C, Greggio NA, Volpato M |title=Clinical review 93: Autoimmune polyglandular syndrome type 1 |journal=J. Clin. Endocrinol. Metab. |volume=83 |issue=4 |pages=1049–55 |year=1998 |pmid=9543115 |doi=10.1210/jcem.83.4.4682 |url=}}</ref> | APS type 1 commonly presents in infancy. The symptoms include:<ref name="pmid22460196">{{cite journal |vauthors=Weiler FG, Dias-da-Silva MR, Lazaretti-Castro M |title=Autoimmune polyendocrine syndrome type 1: case report and review of literature |journal=Arq Bras Endocrinol Metabol |volume=56 |issue=1 |pages=54–66 |year=2012 |pmid=22460196 |doi= |url=}}</ref><ref name="pmid17202607">{{cite journal |vauthors=Joshi RR, Rao S, Prabhu SS |title=Polyglandular autoimmune syndrome-type I |journal=Indian Pediatr |volume=43 |issue=12 |pages=1085–7 |year=2006 |pmid=17202607 |doi= |url=}}</ref><ref name="pmid19411300">{{cite journal |vauthors=Kahaly GJ |title=Polyglandular autoimmune syndromes |journal=Eur. J. Endocrinol. |volume=161 |issue=1 |pages=11–20 |year=2009 |pmid=19411300 |doi=10.1530/EJE-09-0044 |url=}}</ref><ref name="pmid24503135">{{cite journal |vauthors=Charmandari E, Nicolaides NC, Chrousos GP |title=Adrenal insufficiency |journal=Lancet |volume=383 |issue=9935 |pages=2152–67 |year=2014 |pmid=24503135 |doi=10.1016/S0140-6736(13)61684-0 |url=}}</ref><ref name="pmid2348835">{{cite journal |vauthors=Ahonen P, Myllärniemi S, Sipilä I, Perheentupa J |title=Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients |journal=N. Engl. J. Med. |volume=322 |issue=26 |pages=1829–36 |year=1990 |pmid=2348835 |doi=10.1056/NEJM199006283222601 |url=}}</ref><ref name="pmid9543115">{{cite journal |vauthors=Betterle C, Greggio NA, Volpato M |title=Clinical review 93: Autoimmune polyglandular syndrome type 1 |journal=J. Clin. Endocrinol. Metab. |volume=83 |issue=4 |pages=1049–55 |year=1998 |pmid=9543115 |doi=10.1210/jcem.83.4.4682 |url=}}</ref> | ||
* The most common [[symptoms]] of APS-1 include mucocutaneous [[candidiasis]], [[hypoparathyroidism]] and [[Addison's disease]]. In APS type 1, the time interval between onset of one [[endocrinopathy]] to another may take up to years or decades. This condition is also termed as APECED (autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy). | * The most common [[symptoms]] of APS-1 include mucocutaneous [[candidiasis]], [[hypoparathyroidism]] and [[Addison's disease]]. In APS type 1, the time interval between onset of one [[endocrinopathy]] to another may take up to years or decades. This condition is also termed as APECED (autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy). | ||
** The most common and the first presentation of APS type 1 is [[candidiasis]] (seen in children less than 5 years). These patients commonly have recurrent monilial [[infection]]. The [[fungal]] infection is mostly often limited to the [[oral]] and [[anal]] [[mucosa]] and presents with recurrent [[itching]], soreness, painful rash in the genital area and [[discharge]]. | ** The most common and the first presentation of APS type 1 is [[candidiasis]] (seen in children less than 5 years). These patients commonly have recurrent monilial [[infection]]. The [[fungal]] infection is mostly often limited to the [[oral]] and [[anal]] [[mucosa]] and presents with recurrent [[itching]], soreness, painful [[Rash (patient information)|rash]] in the [[genital area]] and [[discharge]]. | ||
** The second symptom complex is from [[hypoparathyroidism]] (seen in children younger than 10 years of age). The symptoms include [[tetany]] (hallmark of acute [[hypocalcemia]]), [[paresthesia]], [[carpopedal spasm|carpopedal spasms]], circumoral [[numbness]], fatigue and [[abdominal pain]]. | ** The second symptom complex is from [[hypoparathyroidism]] (seen in children younger than 10 years of age). The [[symptoms]] include [[tetany]] (hallmark of acute [[hypocalcemia]]), [[paresthesia]], [[carpopedal spasm|carpopedal spasms]], circumoral [[numbness]], fatigue and [[abdominal pain]]. | ||
** [[Addison's disease]] generally presents in [[patients]] < 15 years of age. The common [[symptoms]] of [[Addison's]] include [[weakness]], [[fatigue]], [[weight loss]], [[anorexia]], [[nausea]], [[vomiting]], [[diarrhea]] and [[orthostatic hypotension]]. | ** [[Addison's disease]] generally presents in [[patients]] < 15 years of age. The common [[symptoms]] of [[Addison's]] include [[weakness]], [[fatigue]], [[weight loss]], [[anorexia]], [[nausea]], [[vomiting]], [[diarrhea]] and [[orthostatic hypotension]]. | ||
** Other APS-1 associated diseases include [[autoimmune hepatitis]], [[primary hypothyroidism]], a [[malabsorption]] syndrome, [[vitiligo]], [[pernicious anemia]], [[type 1 diabetes]], [[alopecia]], primary [[hypogonadism]], [[cutaneous]] abnormalities, [[pulmonary disease]], [[ovarian failure]], [[pericarditis]], [[Cerebellar Degeneration|cerebellar degeneration]], [[encephalopathy]], [[asplenia]], [[esophageal cancer]], [[polyneuropathy]], [[pure red cell aplasia]] and others. | ** Other APS-1 associated diseases include [[autoimmune hepatitis]], [[primary hypothyroidism]], a [[malabsorption]] syndrome, [[vitiligo]], [[pernicious anemia]], [[type 1 diabetes]], [[alopecia]], primary [[hypogonadism]], [[cutaneous]] abnormalities, [[pulmonary disease]], [[ovarian failure]], [[pericarditis]], [[Cerebellar Degeneration|cerebellar degeneration]], [[encephalopathy]], [[asplenia]], [[esophageal cancer]], [[polyneuropathy]], [[pure red cell aplasia]] and others. | ||
====Autoimmune polyendocrine syndrome (APS) type 2==== | ====Autoimmune polyendocrine syndrome (APS) type 2==== | ||
APS type 2 commonly presents in infancy and adulthood. The symptoms include:<ref name="pmid26071578">{{cite journal |vauthors=Cyniak-Magierska A, Lasoń A, Smyczyńska J, Lewiński A |title=Autoimmune polyglandular syndrome type 2 manifested as Hashimoto's thyroiditis and adrenocortical insufficiency, in Turner syndrome woman, with onset following introduction of treatment with recombinant human growth hormone |journal=Neuro Endocrinol. Lett. |volume=36 |issue=2 |pages=119–23 |year=2015 |pmid=26071578 |doi= |url=}}</ref><ref name="pmid12050123">{{cite journal |vauthors=Betterle C, Dal Pra C, Mantero F, Zanchetta R |title=Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction |journal=Endocr. Rev. |volume=23 |issue=3 |pages=327–64 |year=2002 |pmid=12050123 |doi=10.1210/edrv.23.3.0466 |url=}}</ref><ref name="pmid17375512">{{cite journal |vauthors=Majeroni BA, Patel P |title=Autoimmune polyglandular syndrome, type II |journal=Am Fam Physician |volume=75 |issue=5 |pages=667–70 |year=2007 |pmid=17375512 |doi= |url=}}</ref> | APS type 2 commonly presents in [[infancy]] and adulthood. The [[symptoms]] include:<ref name="pmid26071578">{{cite journal |vauthors=Cyniak-Magierska A, Lasoń A, Smyczyńska J, Lewiński A |title=Autoimmune polyglandular syndrome type 2 manifested as Hashimoto's thyroiditis and adrenocortical insufficiency, in Turner syndrome woman, with onset following introduction of treatment with recombinant human growth hormone |journal=Neuro Endocrinol. Lett. |volume=36 |issue=2 |pages=119–23 |year=2015 |pmid=26071578 |doi= |url=}}</ref><ref name="pmid12050123">{{cite journal |vauthors=Betterle C, Dal Pra C, Mantero F, Zanchetta R |title=Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction |journal=Endocr. Rev. |volume=23 |issue=3 |pages=327–64 |year=2002 |pmid=12050123 |doi=10.1210/edrv.23.3.0466 |url=}}</ref><ref name="pmid17375512">{{cite journal |vauthors=Majeroni BA, Patel P |title=Autoimmune polyglandular syndrome, type II |journal=Am Fam Physician |volume=75 |issue=5 |pages=667–70 |year=2007 |pmid=17375512 |doi= |url=}}</ref> | ||
* The most common [[symptoms]] of APS-2 include [[Addison's disease]] with [[autoimmune thyroiditis]] or [[diabetes mellitus type 1]]. Other common presentation include primary [[hypogonadism]], [[myasthenia gravis]] and [[celiac disease]]. | * The most common [[symptoms]] of APS-2 include [[Addison's disease]] with [[autoimmune thyroiditis]] or [[diabetes mellitus type 1]]. Other common presentation include primary [[hypogonadism]], [[myasthenia gravis]] and [[celiac disease]]. | ||
**The common [[symptoms]] of [[autoimmune thyroiditis]] and [[hypothyroidism]] are [[fatigue]], [[cold]] intolerance, decreased [[sweating]], [[hypothermia]], coarse skin, [[weight gain]], [[depression]], [[emotional lability]], and [[attention deficit]]. | **The common [[symptoms]] of [[autoimmune thyroiditis]] and [[hypothyroidism]] are [[fatigue]], [[cold]] intolerance, decreased [[sweating]], [[hypothermia]], coarse [[skin]], [[weight gain]], [[depression]], [[emotional lability]], and [[attention deficit]]. | ||
**[[Diabetes mellitus type 1]] presents | **[[Diabetes mellitus type 1]] presents either as classic new onset, with persistent [[thirst]], [[frequent urination]], and [[dehydration]], or as [[diabetic ketoacidosis]], which commonly presents with [[abdominal pain]], [[vomiting]] and [[Flu|flu-like symptoms]]. | ||
** [[Grave's disease]] commonly presents with [[palpitations]], [[tremor]] (usually fine shaking of [[hands]]), [[excessive sweating]], [[heat]] intolerance, increased [[appetite]], unexplained [[weight loss]] despite increased [[appetite]], muscle [[weakness]], [[insomnia]] and increased [[energy]]. | ** [[Grave's disease]] commonly presents with [[palpitations]], [[tremor]] (usually fine shaking of [[hands]]), [[excessive sweating]], [[heat]] intolerance, increased [[appetite]], unexplained [[weight loss]] despite increased [[appetite]], [[muscle]] [[weakness]], [[insomnia]] and increased [[energy]]. | ||
**[[Celiac disease]] | **[[Celiac disease]] commonly presents with [[weight loss]], [[steatorrhea]], [[bloating]], [[cramping]], and [[malnutrition]]. | ||
====Autoimmune polyendocrine syndrome (APS) type 3==== | ====Autoimmune polyendocrine syndrome (APS) type 3==== | ||
APS type 3 commonly presents in neonatal period. The symptoms include:<ref name="pmid12951278">{{cite journal |vauthors=Shimomura H, Nakase Y, Furuta H, Nishi M, Nakao T, Hanabusa T, Sasaki H, Okamoto K, Furukawa F, Nanjo K |title=A rare case of autoimmune polyglandular syndrome type 3 |journal=Diabetes Res. Clin. Pract. |volume=61 |issue=2 |pages=103–8 |year=2003 |pmid=12951278 |doi= |url=}}</ref><ref name="pmid16946565">{{cite journal |vauthors=Oki K, Yamane K, Koide J, Mandai K, Nakanishi S, Fujikawa R, Kohno N |title=A case of polyglandular autoimmune syndrome type III complicated with autoimmune hepatitis |journal=Endocr. J. |volume=53 |issue=5 |pages=705–9 |year=2006 |pmid=16946565 |doi= |url=}}</ref><ref name="pmid19289325">{{cite journal |vauthors=Sheehan MT, Islam R |title=Silent thyroiditis, isolated corticotropin deficiency, and alopecia universalis in a patient with ulcerative colitis and elevated levels of plasma factor VIII: an unusual case of autoimmune polyglandular syndrome type 3 |journal=Endocr Pract |volume=15 |issue=2 |pages=138–42 |year=2009 |pmid=19289325 |doi=10.4158/EP.15.2.138 |url=}}</ref> | APS type 3 commonly presents in [[neonatal]] period. The [[symptoms]] include:<ref name="pmid12951278">{{cite journal |vauthors=Shimomura H, Nakase Y, Furuta H, Nishi M, Nakao T, Hanabusa T, Sasaki H, Okamoto K, Furukawa F, Nanjo K |title=A rare case of autoimmune polyglandular syndrome type 3 |journal=Diabetes Res. Clin. Pract. |volume=61 |issue=2 |pages=103–8 |year=2003 |pmid=12951278 |doi= |url=}}</ref><ref name="pmid16946565">{{cite journal |vauthors=Oki K, Yamane K, Koide J, Mandai K, Nakanishi S, Fujikawa R, Kohno N |title=A case of polyglandular autoimmune syndrome type III complicated with autoimmune hepatitis |journal=Endocr. J. |volume=53 |issue=5 |pages=705–9 |year=2006 |pmid=16946565 |doi= |url=}}</ref><ref name="pmid19289325">{{cite journal |vauthors=Sheehan MT, Islam R |title=Silent thyroiditis, isolated corticotropin deficiency, and alopecia universalis in a patient with ulcerative colitis and elevated levels of plasma factor VIII: an unusual case of autoimmune polyglandular syndrome type 3 |journal=Endocr Pract |volume=15 |issue=2 |pages=138–42 |year=2009 |pmid=19289325 |doi=10.4158/EP.15.2.138 |url=}}</ref> | ||
*The most common [[symptoms]] of APS 3 include [[autoimmune thyroiditis]], [[diabetes mellitus type 1]], [[pernicious anemia]] and/or with involvement of a | *The most common [[symptoms]] of APS 3 include [[autoimmune thyroiditis]], [[diabetes mellitus type 1]], [[pernicious anemia]] and/or with involvement of a non-[[endocrine]] [[Organ (anatomy)|organ]]. (A major difference between APS type 3 and other sub-types is the absence of [[Addison's disease]] in APS type 3.) | ||
*Patients with APS type 3 (IPEX) presents in the [[perinatal period]] or in early [[infancy]] with [[chronic diarrhea]] due to [[autoimmune enteropathy]] or [[diabetes mellitus]]. | *Patients with APS type 3 (IPEX) presents in the [[perinatal period]] or in early [[infancy]] with [[chronic diarrhea]] due to [[autoimmune enteropathy]] or [[diabetes mellitus]]. | ||
*The [[symptoms]] of APS type 3 may wax and wane over the course of time and can be worsened by [[infections]] or [[Vaccinations|vaccination]]. | *The [[symptoms]] of APS type 3 may wax and wane over the course of time and can be worsened by [[infections]] or [[Vaccinations|vaccination]]. | ||
Latest revision as of 22:07, 27 October 2017
|
Autoimmune polyendocrine syndrome Microchapters |
|
Differentiating Autoimmune polyendocrine syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Autoimmune polyendocrine syndrome history and symptoms On the Web |
|
American Roentgen Ray Society Images of Autoimmune polyendocrine syndrome history and symptoms |
|
FDA on Autoimmune polyendocrine syndrome history and symptoms |
|
CDC on Autoimmune polyendocrine syndrome history and symptoms |
|
Autoimmune polyendocrine syndrome history and symptoms in the news |
|
Blogs on Autoimmune polyendocrine syndrome history and symptoms |
|
Directions to Hospitals Treating Autoimmune polyendocrine syndrome |
|
Risk calculators and risk factors for Autoimmune polyendocrine syndrome history and symptoms |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Akshun Kalia M.B.B.S.[2]
Overview
A detailed history may be helpful in the early diagnosis of the autoimmune polyendocrine syndrome (APS). Autoimmune polyendocrine syndrome patients generally have an early onset. In such cases, history from the caregivers may be obtained. An important aspect involves obtaining family history about the presence of APS in family members since APS can be transmitted in genetic mode. Patients with the autoimmune polyendocrine syndrome (APS) have varied symptoms depending on the subtype. The most common presentation of APS-1 include mucocutaneous candidiasis, hypoparathyroidism and Addison's disease. The most common presentation of APS-2 include Addison's disease with autoimmune thyroiditis or diabetes mellitus type 1. The most common presentation of APS 3 include autoimmune thyroiditis, diabetes mellitus type 1, pernicious anemia and/or with involvement of a non-endocrine organ.
History
Obtaining a detailed history is an important aspect in making a diagnosis of autoimmune polyendocrine syndrome (APS). It provides insight into the cause, precipitating factors and associated comorbid conditions. It also helps in determining the correct therapy and the prognosis. Autoimmune polyendocrine syndrome patients generally have an early onset. In such cases history from the care givers or the family members may need to be obtained. Specific areas of focus while obtaining history, are outlined below:[1][2][3]
- Onset, duration and progression of symptoms (mucocutaneous candidiasis, hypoparathyroidism and adrenal failure)
- Any family history of similar symptoms or autoimmune polyendocrine syndrome (APS)
- History of recurrent infections (to rule out immunodeficiency)
- Associated symptoms (lethargy, fever, confusion)
- Medications
- Symptoms of other organ failure (renal failure, liver failure, adrenal failure)
- Comorbid conditions like diabetes, immunodeficiency
- Severe infections
- Any dehydration history for severe loss of fluids
Symptoms
Patients with autoimmune polyendocrine syndrome (APS) have varied symptoms depending upon the subtype.
Autoimmune polyendocrine syndrome (APS) type 1
APS type 1 commonly presents in infancy. The symptoms include:[4][5][6][7][8][9]
- The most common symptoms of APS-1 include mucocutaneous candidiasis, hypoparathyroidism and Addison's disease. In APS type 1, the time interval between onset of one endocrinopathy to another may take up to years or decades. This condition is also termed as APECED (autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy).
- The most common and the first presentation of APS type 1 is candidiasis (seen in children less than 5 years). These patients commonly have recurrent monilial infection. The fungal infection is mostly often limited to the oral and anal mucosa and presents with recurrent itching, soreness, painful rash in the genital area and discharge.
- The second symptom complex is from hypoparathyroidism (seen in children younger than 10 years of age). The symptoms include tetany (hallmark of acute hypocalcemia), paresthesia, carpopedal spasms, circumoral numbness, fatigue and abdominal pain.
- Addison's disease generally presents in patients < 15 years of age. The common symptoms of Addison's include weakness, fatigue, weight loss, anorexia, nausea, vomiting, diarrhea and orthostatic hypotension.
- Other APS-1 associated diseases include autoimmune hepatitis, primary hypothyroidism, a malabsorption syndrome, vitiligo, pernicious anemia, type 1 diabetes, alopecia, primary hypogonadism, cutaneous abnormalities, pulmonary disease, ovarian failure, pericarditis, cerebellar degeneration, encephalopathy, asplenia, esophageal cancer, polyneuropathy, pure red cell aplasia and others.
Autoimmune polyendocrine syndrome (APS) type 2
APS type 2 commonly presents in infancy and adulthood. The symptoms include:[10][11][12]
- The most common symptoms of APS-2 include Addison's disease with autoimmune thyroiditis or diabetes mellitus type 1. Other common presentation include primary hypogonadism, myasthenia gravis and celiac disease.
- The common symptoms of autoimmune thyroiditis and hypothyroidism are fatigue, cold intolerance, decreased sweating, hypothermia, coarse skin, weight gain, depression, emotional lability, and attention deficit.
- Diabetes mellitus type 1 presents either as classic new onset, with persistent thirst, frequent urination, and dehydration, or as diabetic ketoacidosis, which commonly presents with abdominal pain, vomiting and flu-like symptoms.
- Grave's disease commonly presents with palpitations, tremor (usually fine shaking of hands), excessive sweating, heat intolerance, increased appetite, unexplained weight loss despite increased appetite, muscle weakness, insomnia and increased energy.
- Celiac disease commonly presents with weight loss, steatorrhea, bloating, cramping, and malnutrition.
Autoimmune polyendocrine syndrome (APS) type 3
APS type 3 commonly presents in neonatal period. The symptoms include:[13][14][15]
- The most common symptoms of APS 3 include autoimmune thyroiditis, diabetes mellitus type 1, pernicious anemia and/or with involvement of a non-endocrine organ. (A major difference between APS type 3 and other sub-types is the absence of Addison's disease in APS type 3.)
- Patients with APS type 3 (IPEX) presents in the perinatal period or in early infancy with chronic diarrhea due to autoimmune enteropathy or diabetes mellitus.
- The symptoms of APS type 3 may wax and wane over the course of time and can be worsened by infections or vaccination.
- Other common symptoms include eczematous dermatitis, autoimmune hemolytic anemia and glomerulonephritis.
References
- ↑ De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, Nicolaides NC, Chrousos, Charmandari E. PMID 25905309. Missing or empty
|title=(help) - ↑ Halonen M, Eskelin P, Myhre AG, Perheentupa J, Husebye ES, Kämpe O, Rorsman F, Peltonen L, Ulmanen I, Partanen J (2002). "AIRE mutations and human leukocyte antigen genotypes as determinants of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy phenotype". J. Clin. Endocrinol. Metab. 87 (6): 2568–74. doi:10.1210/jcem.87.6.8564. PMID 12050215.
- ↑ Borgaonkar MR, Morgan DG (1999). "Primary biliary cirrhosis and type II autoimmune polyglandular syndrome". Can. J. Gastroenterol. 13 (9): 767–70. PMID 10633830.
- ↑ Weiler FG, Dias-da-Silva MR, Lazaretti-Castro M (2012). "Autoimmune polyendocrine syndrome type 1: case report and review of literature". Arq Bras Endocrinol Metabol. 56 (1): 54–66. PMID 22460196.
- ↑ Joshi RR, Rao S, Prabhu SS (2006). "Polyglandular autoimmune syndrome-type I". Indian Pediatr. 43 (12): 1085–7. PMID 17202607.
- ↑ Kahaly GJ (2009). "Polyglandular autoimmune syndromes". Eur. J. Endocrinol. 161 (1): 11–20. doi:10.1530/EJE-09-0044. PMID 19411300.
- ↑ Charmandari E, Nicolaides NC, Chrousos GP (2014). "Adrenal insufficiency". Lancet. 383 (9935): 2152–67. doi:10.1016/S0140-6736(13)61684-0. PMID 24503135.
- ↑ Ahonen P, Myllärniemi S, Sipilä I, Perheentupa J (1990). "Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients". N. Engl. J. Med. 322 (26): 1829–36. doi:10.1056/NEJM199006283222601. PMID 2348835.
- ↑ Betterle C, Greggio NA, Volpato M (1998). "Clinical review 93: Autoimmune polyglandular syndrome type 1". J. Clin. Endocrinol. Metab. 83 (4): 1049–55. doi:10.1210/jcem.83.4.4682. PMID 9543115.
- ↑ Cyniak-Magierska A, Lasoń A, Smyczyńska J, Lewiński A (2015). "Autoimmune polyglandular syndrome type 2 manifested as Hashimoto's thyroiditis and adrenocortical insufficiency, in Turner syndrome woman, with onset following introduction of treatment with recombinant human growth hormone". Neuro Endocrinol. Lett. 36 (2): 119–23. PMID 26071578.
- ↑ Betterle C, Dal Pra C, Mantero F, Zanchetta R (2002). "Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction". Endocr. Rev. 23 (3): 327–64. doi:10.1210/edrv.23.3.0466. PMID 12050123.
- ↑ Majeroni BA, Patel P (2007). "Autoimmune polyglandular syndrome, type II". Am Fam Physician. 75 (5): 667–70. PMID 17375512.
- ↑ Shimomura H, Nakase Y, Furuta H, Nishi M, Nakao T, Hanabusa T, Sasaki H, Okamoto K, Furukawa F, Nanjo K (2003). "A rare case of autoimmune polyglandular syndrome type 3". Diabetes Res. Clin. Pract. 61 (2): 103–8. PMID 12951278.
- ↑ Oki K, Yamane K, Koide J, Mandai K, Nakanishi S, Fujikawa R, Kohno N (2006). "A case of polyglandular autoimmune syndrome type III complicated with autoimmune hepatitis". Endocr. J. 53 (5): 705–9. PMID 16946565.
- ↑ Sheehan MT, Islam R (2009). "Silent thyroiditis, isolated corticotropin deficiency, and alopecia universalis in a patient with ulcerative colitis and elevated levels of plasma factor VIII: an unusual case of autoimmune polyglandular syndrome type 3". Endocr Pract. 15 (2): 138–42. doi:10.4158/EP.15.2.138. PMID 19289325.